ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Disease progression | 08.01.03.038 | 0.010928% | | |
Hepatobiliary disease | 09.01.08.003 | - | - | Not Available |
Metastasis | 16.22.01.001 | 0.006725% | | Not Available |
Renal impairment | 20.01.03.010 | 0.022556% | | Not Available |
Unevaluable event | 08.01.03.051 | - | - | Not Available |
Osteonecrosis of jaw | 24.04.05.005; 15.02.04.010 | 0.067667% | | |
Bone marrow failure | 01.03.03.005 | 0.012889% | | |
Treatment failure | 08.06.01.017 | 0.003362% | | Not Available |
Liver injury | 12.01.02.003; 09.01.07.022 | 0.006444% | | Not Available |
Organising pneumonia | 22.01.02.008 | 0.001681% | | Not Available |
Type 2 diabetes mellitus | 05.06.01.003; 14.06.01.003 | - | - | Not Available |
Epidural lipomatosis | 17.10.01.012; 14.08.04.019 | 0.006444% | | Not Available |
Hypertransaminasaemia | 09.01.02.005 | - | - | Not Available |
Acute kidney injury | 20.01.03.016 | 0.077334% | | |
Drug-induced liver injury | 12.03.01.044; 09.01.07.023 | 0.016111% | | Not Available |
Hepatic cancer | 09.04.02.008; 16.07.02.004 | 0.001681% | | Not Available |
Hepatocellular carcinoma | 16.07.02.005; 09.04.02.010 | 0.001681% | | Not Available |
Multiple organ dysfunction syndrome | 08.01.03.057 | 0.010087% | | |
Anal incontinence | 17.05.01.021; 07.01.06.029 | 0.019333% | | |
Liver function test increased | 13.03.01.044 | 0.006444% | | Not Available |
Blood testosterone abnormal | 13.10.05.001 | 0.012889% | | Not Available |
Chronic respiratory failure | 14.01.04.005; 22.02.06.005 | 0.001681% | | Not Available |
Cystitis radiation | 20.03.02.009; 12.05.02.009 | 0.009667% | | Not Available |
Metastases to bone | 16.22.02.005; 15.09.03.006 | 0.048333% | | Not Available |
Metastases to breast | 21.05.01.024; 16.22.02.014 | 0.001681% | | Not Available |
Metastases to lymph nodes | 16.22.02.006; 01.09.01.015 | 0.004203% | | Not Available |
Prostate cancer recurrent | 21.04.02.008; 16.25.01.005 | 0.009667% | | Not Available |
Prostatic haemorrhage | 24.07.03.028; 21.04.01.009 | 0.009667% | | |
Prostatic specific antigen decreased | 13.22.01.002 | 0.006444% | | Not Available |
Radiation proctitis | 12.05.02.012; 07.08.04.003 | 0.006444% | | Not Available |